Live attenuated influenza vaccine (FluMist®; Fluenz™): a review of its use in the prevention of seasonal influenza in children and adults (Q37921281)

From Wikidata

Jump to navigation Jump to search

scientific article published on August 2011

Language	Label	Description	Also known as
English	Live attenuated influenza vaccine (FluMist®; Fluenz™): a review of its use in the prevention of seasonal influenza in children and adults	scientific article published on August 2011

Statements

scholarly article

1 reference

Europe PubMed Central

25 August 2017

1 reference

Europe PubMed Central

Live attenuated influenza vaccine (FluMist®; Fluenz™): a review of its use in the prevention of seasonal influenza in children and adults (English)

1 reference

Europe PubMed Central

25 August 2017

attenuated vaccine

1 reference

based on heuristic

inferred from title

influenza vaccine

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Monique P Curran

2

object named as

Monique P Curran

1 reference

Europe PubMed Central

25 August 2017

author name string

Natalie J Carter

1

1 reference

Europe PubMed Central

25 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 August 2011

1 reference

Europe PubMed Central

25 August 2017

1 reference

Europe PubMed Central

25 August 2017

71

1 reference

Europe PubMed Central

25 August 2017

12

1 reference

Europe PubMed Central

25 August 2017

1591-1622

1 reference

Europe PubMed Central

25 August 2017

https://scigraph.springernature.com/pub.10.2165/11206860-000000000-00000

0 references

Influenza vaccines for the future

1 reference

https://api.crossref.org/works/10.2165%2F11206860-000000000-00000

21 January 2018

Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis.

1 reference

https://api.crossref.org/works/10.2165%2F11206860-000000000-00000

21 January 2018

Flu myths: dispelling the myths associated with live attenuated influenza vaccine

1 reference

https://api.crossref.org/works/10.2165%2F11206860-000000000-00000

21 January 2018

Genetic stability of live, cold-adapted influenza virus components of the FluMist/CAIV-T vaccine throughout the manufacturing process

1 reference

https://api.crossref.org/works/10.2165%2F11206860-000000000-00000

21 January 2018

Current status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenza.

1 reference

https://api.crossref.org/works/10.2165%2F11206860-000000000-00000

21 January 2018

Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia

1 reference

https://api.crossref.org/works/10.2165%2F11206860-000000000-00000

21 January 2018

Safety, efficacy, and effectiveness of cold-adapted influenza vaccine-trivalent against community-acquired, culture-confirmed influenza in young children attending day care

1 reference

https://api.crossref.org/works/10.2165%2F11206860-000000000-00000

21 January 2018

Seasonal influenza vaccinations: specialized products for different target groups

1 reference

https://api.crossref.org/works/10.2165%2F11206860-000000000-00000

21 January 2018

Comparative immunogenicities of frozen and refrigerated formulations of live attenuated influenza vaccine in healthy subjects

1 reference

https://api.crossref.org/works/10.2165%2F11206860-000000000-00000

21 January 2018

Live attenuated versus inactivated influenza vaccine in infants and young children.

1 reference

https://api.crossref.org/works/10.2165%2F11206860-000000000-00000

21 January 2018

Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma

1 reference

https://api.crossref.org/works/10.2165%2F11206860-000000000-00000

21 January 2018

Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine

1 reference

https://api.crossref.org/works/10.2165%2F11206860-000000000-00000

21 January 2018

The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children

1 reference

https://api.crossref.org/works/10.2165%2F11206860-000000000-00000

21 January 2018

Genetic sequence analysis of influenza viruses and illness severity in ill children previously vaccinated with live attenuated or inactivated influenza vaccine

1 reference

https://api.crossref.org/works/10.2165%2F11206860-000000000-00000

21 January 2018

The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults

1 reference

https://api.crossref.org/works/10.2165%2F11206860-000000000-00000

21 January 2018

Safety and efficacy of live attenuated influenza vaccine in children 2-7 years of age.

1 reference

https://api.crossref.org/works/10.2165%2F11206860-000000000-00000

21 January 2018

The efficacy of live attenuated and inactivated influenza vaccines in children as a function of time postvaccination

1 reference

https://api.crossref.org/works/10.2165%2F11206860-000000000-00000

21 January 2018

Efficacy of live attenuated influenza vaccine in children 6 months to 17 years of age.

1 reference

https://api.crossref.org/works/10.2165%2F11206860-000000000-00000

21 January 2018

Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children

1 reference

https://api.crossref.org/works/10.2165%2F11206860-000000000-00000

21 January 2018

Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.2165%2F11206860-000000000-00000

21 January 2018

Comparative efficacy of inactivated and live attenuated influenza vaccines

1 reference

https://api.crossref.org/works/10.2165%2F11206860-000000000-00000

21 January 2018

Countywide school-based influenza immunization: direct and indirect impact on student absenteeism

1 reference

https://api.crossref.org/works/10.2165%2F11206860-000000000-00000

21 January 2018

Direct and indirect effectiveness of influenza vaccination delivered to children at school preceding an epidemic caused by 3 new influenza virus variants

1 reference

https://api.crossref.org/works/10.2165%2F11206860-000000000-00000

21 January 2018

Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses

1 reference

https://api.crossref.org/works/10.2165%2F11206860-000000000-00000

21 January 2018

Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents

1 reference

https://api.crossref.org/works/10.2165%2F11206860-000000000-00000

21 January 2018

Effect of yearly vaccinations with live, attenuated, cold-adapted, trivalent, intranasal influenza vaccines on antibody responses in children.

1 reference

https://api.crossref.org/works/10.2165%2F11206860-000000000-00000

21 January 2018

Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults

1 reference

https://api.crossref.org/works/10.2165%2F11206860-000000000-00000

21 January 2018

Shedding of live vaccine virus, comparative safety, and influenza-specific antibody responses after administration of live attenuated and inactivated trivalent influenza vaccines to HIV-infected children

1 reference

https://api.crossref.org/works/10.2165%2F11206860-000000000-00000

21 January 2018

Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age.

1 reference

https://api.crossref.org/works/10.2165%2F11206860-000000000-00000

21 January 2018

A multinational, randomized, placebo-controlled trial to assess the immunogenicity, safety, and tolerability of live attenuated influenza vaccine coadministered with oral poliovirus vaccine in healthy young children

1 reference

https://api.crossref.org/works/10.2165%2F11206860-000000000-00000

21 January 2018

Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine

1 reference

https://api.crossref.org/works/10.2165%2F11206860-000000000-00000

21 January 2018

A randomized, double-blind study of the safety, transmissibility and phenotypic and genotypic stability of cold-adapted influenza virus vaccine

1 reference

https://api.crossref.org/works/10.2165%2F11206860-000000000-00000

21 January 2018

Anti-influenza serum and mucosal antibody responses after administration of live attenuated or inactivated influenza vaccines to HIV-infected children

1 reference

https://api.crossref.org/works/10.2165%2F11206860-000000000-00000

21 January 2018

Duration of virus shedding after trivalent intranasal live attenuated influenza vaccination in adults

1 reference

https://api.crossref.org/works/10.2165%2F11206860-000000000-00000

21 January 2018

Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines

1 reference

https://api.crossref.org/works/10.2165%2F11206860-000000000-00000

21 January 2018

Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines.

1 reference

https://api.crossref.org/works/10.2165%2F11206860-000000000-00000

21 January 2018

Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America.

1 reference

https://api.crossref.org/works/10.2165%2F11206860-000000000-00000

21 January 2018

Seasonal influenza and vaccination coverage

1 reference

https://api.crossref.org/works/10.2165%2F11206860-000000000-00000

21 January 2018

The 2009-2010 influenza pandemic: effects on pandemic and seasonal vaccine uptake and lessons learned for seasonal vaccination campaigns

1 reference

https://api.crossref.org/works/10.2165%2F11206860-000000000-00000

21 January 2018

Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine-naive children

1 reference

https://api.crossref.org/works/10.2165%2F11206860-000000000-00000

21 January 2018

Reye's syndrome: the case for a causal link with aspirin

1 reference

https://api.crossref.org/works/10.2165%2F11206860-000000000-00000

21 January 2018

Update on influenza A (H1N1) 2009 monovalent vaccines.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21861544

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of otitis media in children with live attenuated influenza vaccine given intranasally

1 reference

https://pubmed.ncbi.nlm.nih.gov/21861544

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age

1 reference

https://pubmed.ncbi.nlm.nih.gov/21861544

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children

1 reference

https://pubmed.ncbi.nlm.nih.gov/21861544

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Efficacy of Live Attenuated Influenza Vaccine Against Influenza-associated Acute Otitis Media in Children

1 reference

https://pubmed.ncbi.nlm.nih.gov/21861544

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An integrated, multistudy analysis of the safety of Ann Arbor strain live attenuated influenza vaccine in children aged 2-17 years

1 reference

https://pubmed.ncbi.nlm.nih.gov/21861544

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mucosal immune response to trivalent live attenuated intranasal influenza vaccine in children

1 reference

https://pubmed.ncbi.nlm.nih.gov/21861544

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness of school-based influenza vaccination

1 reference

https://pubmed.ncbi.nlm.nih.gov/21861544

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21861544

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Superior Relative Efficacy of Live Attenuated Influenza Vaccine Compared With Inactivated Influenza Vaccine in Young Children With Recurrent Respiratory Tract Infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/21861544

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21861544

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/11206860-000000000-00000

1 reference

Europe PubMed Central

25 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

25 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37921281&oldid=2105033940"